MERIT MEDICAL SYSTEMS INC (MMSI) FY2026 YTD Q2 P&L / Income Statement

MERIT MEDICAL SYSTEMS INC (MMSI) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

800,720,000 US dollars

Cost of sales

400,757,000 US dollars

Gross profit

399,963,000 US dollars

Total operating expenses

295,403,000 US dollars

Income from operations

104,560,000 US dollars

Total other (expense) income - net

300,000 US dollars

Income before income taxes

104,860,000 US dollars

Income tax expense

25,062,000 US dollars

Net income

79,798,000 US dollars

Access

312,910,000 US dollars

Foundational, Original Equipment Manufacturer

87,878,000 US dollars

Procedural Solutions

54,437,000 US dollars

Vascular Intervention

80,690,000 US dollars

Other

525,000 US dollars

Cardiac Therapies

55,914,000 US dollars

Endoscopy

45,339,000 US dollars

Therapeutic, Original Equipment Manufacturer

20,276,000 US dollars

Oncology

49,282,000 US dollars

Renal Therapies

24,225,000 US dollars

Vascular Intervention

69,244,000 US dollars

Selling, general and administrative

247,439,000 US dollars

Research and development

47,998,000 US dollars

Contingent consideration expense (benefit)

negative 34,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.